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Surveillance is an essential component of global programs to eliminate infectious diseases
and avert epidemics of (re-)emerging diseases. As the numbers of cases decline, costs of
treatment and control diminish but those for surveillance remain high even after the ‘last’
case. Reducing surveillance may risk missing persistent or (re-)emerging foci of disease.
Here, we use a simulation-based approach to determine the minimal number of passive sur-
veillance sites required to ensure maximum coverage of a population at-risk (PAR) of an
infectious disease.
Methodology and principal findings
For this study, we use Gambian human African trypanosomiasis (g-HAT) in north-western
Uganda, a neglected tropical disease (NTD) which has been reduced to historically low
levels (<1000 cases/year globally), as an example. To quantify travel time to diagnostic
facilities, a proxy for surveillance coverage, we produced a high spatial-resolution resis-
tance surface and performed cost-distance analyses. We simulated travel time for the
PAR with different numbers (1–170) and locations (170,000 total placement combina-
tions) of diagnostic facilities, quantifying the percentage of the PAR within 1h and 5h
travel of the facilities, as per in-country targets. Our simulations indicate that a 70%
reduction (51/170) in diagnostic centres still exceeded minimal targets of coverage even
for remote populations, with >95% of a total PAR of ~3million individuals living �1h from a
diagnostic centre, and we demonstrate an approach to best place these facilities, inform-
ing a minimal impact scale back.
Conclusions
Our results highlight that surveillance of g-HAT in north-western Uganda can be scaled back
without substantially reducing coverage of the PAR. The methodology described can
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Author summary
Disease surveillance systems are an essential component of public health practice and are
often considered the first line in averting epidemics for (re-)emerging diseases. Regular
evaluation of surveillance systems ensures that they remain operating at maximum effi-
ciency; systems that survey diseases of low incidence, such as those within elimination set-
tings, should be simplified to reduce the reporting burden. A lack of guidance on how to
optimise disease surveillance in an elimination setting may result in added expense, and/
or the underreporting of disease. Here, we propose a framework methodology to deter-
mine systematically the optimal number and placement of surveillance sites for the sur-
veillance of infectious diseases approaching elimination. By utilising estimates of
geographic accessibility, through the construction of a resistance surface and a simulation
approach, we identify that the number of operational diagnostic facilities for Gambian
human African trypanosomiasis in north-western Uganda can be reduced by 70% with a
minimal reduction in existing coverage, and identify the minimum number of facilities
required to meet coverage targets. Our analysis can be used to inform the number and
positioning of surveillance sites for diseases within an elimination setting. Passive surveil-
lance becomes increasingly important as cases decline and active surveillance becomes
less cost-effective; methods to evaluate how best to engage this passive surveillance capac-
ity given facility capacity and geographic distribution are pertinent for several NTDs
where diagnosis is complex. Not only is this a complicated research area for diseases
approaching elimination, a well-designed surveillance system is essential for the detection
of emerging diseases, with this work being topical in a climate where emerging pathogens
are becoming more commonplace.
Introduction
Quantifying the spatial and temporal distribution of cases is essential for the development,
implementation and monitoring of programmes to control or eliminate infectious diseases [1–
3]. In general, costs for treatment and control of a disease scale with the number of cases, but
those for surveillance can be high even when disease incidence is low [4]. Programmes aiming
to eliminate or eradicate a disease maintain high levels of surveillance, as illustrated by the
global programmes against smallpox and polio [5,6]. Similarly, surveillance systems to detect
(re-)emerging diseases may also have relatively large surveillance costs in relation to the num-
bers of cases [7]. Maintaining adequate surveillance for diseases approaching elimination or
with potential for emergence can be prohibitively costly for national health systems, particu-
larly for resource-poor countries in the tropics [8,9], and as such, approaches for cost-effective
surveillance are required.
Neglected tropical diseases (NTDs) cause high levels of mortality and morbidity in some of
the world’s poorest countries [10,11]. A global program aims to eliminate or eradicate eleven
NTDs by 2030 and as the elimination of several NTDs approaches, globally and/or nationally,
there is a pressing need for cost-effective strategies to detect the last remaining cases [12,13].
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The new surveillance strategies will need to be adapted to the disease itself, local health systems
and the population at risk (PAR) [1].
Disease surveillance systems include active, passive, sentinel, and statistical approaches, but
the majority of reportable disease surveillance is conducted through passive surveillance
[14,15]. Passive surveillance is based primarily on compilation of case reports submitted by
healthcare facilities, produced when infected individuals present to the facility for diagnosis
and treatment. One approach to improving cost-effectiveness of passive surveillance is to
quantify the minimal number of surveillance sites that provides maximal coverage of the PAR.
Towards this aim, we combined estimates of travel time to passive surveillance sites with a sim-
ulation-based approach to determine the optimal number of sites required to ensure that 50%
and 95% of a PAR of Gambian human African trypanosomiasis (g-HAT) are within 1-hour
and 5-hours of a diagnostic facility, respectively. The aforementioned criteria come from in-
country targets [16], however, the approach described here can be adapted for a range of
NTDs in an elimination setting, with varying coverage and travel time requirements deter-
mined by national governments, NGOs or other disease surveillance operators.
Scale back in the context of human African trypanosomiasis
Human African trypanosomiasis (HAT, also called ‘sleeping sickness’) is an NTD occurring
across sub-Saharan Africa, caused by sub-species of Trypanosoma brucei transmitted by tsetse
flies. Most (>95%) cases of HAT are caused by T. b. gambiense (g-HAT), for which humans are
the primary host; the remaining ~5% of cases are caused by T. b. rhodesiense (r-HAT) for which
the primary reservoirs are animal hosts [17]. No prophylaxis or vaccine exists for either form of
HAT. Therapeutic drugs are available [18], but the toxic nature of chemotherapy requires that
infection status is confirmed before the patient is treated. Disease prevention and control efforts
focus on the detection and treatment of existing cases and control of the tsetse vector [19].
The World Health Organization (WHO) aims to eliminate g-HAT as a public health prob-
lem by 2030. The definitions of elimination include fewer than 2,000 cases reported per
annum globally, a 90% reduction in areas reporting>1 case in 10,000 per annum compared to
2000–2004, with a country-level indicator of elimination defined as fewer than 1 reported case
per 10,000 people, per annum (averaged over a 5-year period) in each health district, in con-
junction with adequate, functional control and surveillance [20]. Uganda is on track to achieve
this goal with a reduction from 2,757 (range, 310–948 cases/year) cases reported between
2000–2004 to 18 (range, 0–9 cases/year) cases in 2014–18 [21]. These reductions are mostly
attributable to active screening and treatment of the population [22,23], and, more recently,
vector control [24]. For g-HAT, active screening has been the cornerstone of surveillance in
most foci during periods of high case numbers. As case numbers decline this has become
increasingly less cost-effective and surveillance has switched to a passive system.
Plans to scale back the number of passive surveillance sites operating RDTs are ongoing in
Uganda, with the target of ensuring that by 2030,�50% of at-risk populations should live
within 1-hour of a health facility with HAT diagnostics and�95% should live within 5-hours
[16]. The number of health facilities using HAT RDTs were reviewed in July 2014 and Septem-
ber 2015, in response to the evolving epidemiological situation of g-HAT in Uganda [25]. Pre-
vious analyses utilised the Euclidean distance to facilities as opposed to estimates of travel
time. The number of facilities in operation may be further reviewed to better quantify accessi-
bility, identify the minimal number required to ensure sufficient coverage, and to maximise
cost-effectiveness.
Optimisation of passive screening capacity in NW Uganda must consider two key elements.
First, there must be evidence of reduced transmission, be this supported by active screening or
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reduced abundance of tsetse [23,24]. Second, g-HAT has a very long interval between infection
and detection of a case, and cases can remain undetected for some time [26], therefore we are
required to consider the long tail of this case distribution and any reservoirs of infection [27].
Consequently, the resource review proposed here should target a wider area that has been his-
torically at risk in order to detect any residual infections in the area. The streamlining or opti-
misation of the number of facilities might be considered a step towards establishment of a
network of sentinel screening sites to monitor post-elimination [17].
The work described here aims to utilise information on the location of operational HAT
diagnostic facilities, alongside estimates of travel time to said facilities, to inform an analysis
designed to identify the optimal number, and placement of, surveillance facilities required to
meet the in-country coverage targets defined above.
Methods
Study setting
The focal area of this study is north-western Uganda where we focus on seven districts within
the West Nile region which form Uganda’s g-HAT endemic area. These endemic districts are
Arua (2,100 km2), Maracha (693 km2), Koboko (862 km2), Amuru (3,625km2), Adjumani
(3,030km2), Moyo (1,800km2), and Yumbe (1,524 km2). Collectively, these districts have a
population of approximately 3.5 million people [28]. For the purpose of this study, from this
point onwards, we refer to these seven districts as “north-western Uganda”.
High-resolution resistance surface
To quantify travel time to diagnostic facilities, we first sought to generate a resistance surface
for north-western Uganda at a 30m × 30m spatial resolution. Resistance surfaces (also termed
‘friction surfaces’) contain estimates of associated travel cost for gridded cells within a Carte-
sian plane and are used within cost-distance analyses to quantify the effort required to travel
between each cell and an origin point [29]. To construct the resistance surface, we collated
data from a variety of sources. We obtained comprehensive road network data from Open-
StreetMap [30], and assigned travel speeds along differing road classes based off observed
speeds from GPS tracks obtained during February-April 2018 [31]. Speeds were representative
of motorcycle travel, in agreement with the most commonly used mode of transportation in
Uganda [32]. Estimates of off-road travel were generated utilising remotely sensed Landsat-8
data [33], and a normalised difference vegetation index (NDVI) [34,35], paired with informa-
tion from studies detailing travel time through varying vegetation densities [36,37]. Finally, we
combined off-road and on-road travel estimates to produce a comprehensive resistance sur-
face detailing the time taken to traverse through each 30m × 30m gridded cell. We evaluated
the accuracy of the resistance surface by comparing predicted travel time along 1,000 routes
with times derived from Google Maps within a linear regression [38]. An in-depth description
of the process is provided within S1 File.
Health facility data
In 2013, a new passive surveillance strategy was implemented in north-western Uganda, which
saw the number of facilities participating in passive surveillance increase from four to 212,
which was subsequently adjusted to 170 in 2017 [25]. Each facility utilises either RDTs alone
[39], or RDTs and microscopy techniques [40], and is supplemented by mini-anion exchange
centrifugation technique (mAECT) [41], with three of these second group facilities also
equipped with loop-mediated isothermal amplification (LAMP) for identifying suspected g-
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HAT cases (Fig 1A) [42]. For facilities with available data, the number of RDTs used during
2017 is shown within Fig 1B. Facilities operating LAMP and LED diagnostics serve as referral
sites for RDT positive individuals, and are representative of larger facilities with higher quality
services [25].
Human population density data
To detail the number of individuals within HAT risk areas who live within 1-hour and 5-hours
travel time of a HAT diagnostic facility, we utilised a high-resolution population density sur-
face [28]. This surface matched the spatial resolution of the resistance surface generated above
(30m × 30m) and was re-sampled to ensure gridded cells aligned. A crude estimate of the PAR
of g-HAT within the study region was determined by creating a 10km radius buffer around
reported cases between 2000 and 2018 (Fig 2A) [21,25], representative of moderate risk (Fig
2B). Case data were obtained from the WHO HAT atlas [21], and the occurrence locations
represent either the residence of the individual (data collected through active screening), or
the location in which a case was diagnosed (if diagnosed during passive screening). Unfortu-
nately, there is uncertainty surrounding the location of infection with both collection methods,
and one of the advantages of buffering case data is that this approach accounts for some of the
uncertainty surrounding the true location of infection. Several papers quantifying g-HAT risk
similarly use a buffer around case data, albeit a more conservative distance of 30km (see
Fig 1. A: Location of existing HAT diagnostic centres across endemic districts in north-western Uganda (2017, n = 170),
coloured by type of diagnostic method used. B: Number of HAT rapid diagnostic tests (RDTs) used by operational facilities
during 2017. Maps produced in QGIS [43].
https://doi.org/10.1371/journal.pntd.0008599.g001
Fig 2. A: Spatial distribution of g-HAT cases within north-western Uganda, 2000–2018. B: Areas at risk of g-HAT,
identified as locations within 10km of a case. Maps produced in QGIS [43].
https://doi.org/10.1371/journal.pntd.0008599.g002
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Franco et al. 2014 [19], 2017 [17], 2018 [44] and 2020 [20]). The population-at-risk surfaces
within Franco et al. are generated for the whole continent and we believe that, in the absence
of a HAT-risk model, this approach is a good quantification of those at risk within north-west-
ern Uganda. Buffering case data identified 3,025,801 individuals living within at-risk areas
(PAR provided as S1 Data). The PAR surface used in this analysis captures the historic distri-
bution of g-HAT within north-western Uganda and is therefore greater than PAR surfaces
generated using only contemporary data (e.g. Simarro et al. [45]). The inclusion of historic
data (2000–2018) provides higher confidence in the detection of disease and residual cases
from across the area where transmission has occurred previously.
Simulation of accessibility to diagnostic centres under differing placements
Information on the location of existing g-HAT diagnostic facilities may be paired with the
resistance surface to answer any of the following questions:
1. What is the smallest collection of the existing facilities that would meet the coverage
requirements (i.e.�50% of PAR within 1h;�95% within 5h)?
2. What reductions in health facility numbers can be made without significantly reducing cur-
rent levels of coverage with respect to 1h and 5h travel time targets?
3. Given a fixed number of facilities (for example, informed by funding availability or from
answering questions one or two), what is the best spatial placement of said facilities to
ensure maximum coverage of the PAR?
Deriving the optimal number of facilities
To derive the optimal number of facilities required within north-western Uganda to ensure that
�50% of the PAR live less than 1 hour, and�95% of the PAR live less than 5 hours from a health
facility with HAT diagnostics respectively, we performed a simulation study. Suppose Sn is the
set of all possible combinations of n facilities from the 170 currently available. We wish to obtain
an estimate of the average PAR living within 1 or 5 hours of a facility for all possible values of n,
but once n>1, the total number of combinations of n facilities is very large and computationally
prohibitive. As such, we adopted a simulation approach, such that for n = 2,..,170 we generated
Ŝn which consisted of 1,000 random samples of n facilities. For each sample, i = 1,. . .,1000 we cal-
culated the size of the PAR within 1, (Ain) or 5, (B
i
n) hours of any of the n facilities using a cost-
distance analysis implemented within R (version 3.5.1). From this we can obtain Mn, the average
number of people within 1 hour, and Vn, the average number of people within 5 hours of any of
the n facilities (Eqs 1 and 2). Qn represents the proportion of simulations for which more than
50% of the PAR, (D), are within 1 hours travel to any of the n facilities (Eq 3), and Zn represents
the proportion of simulations for which more than 95% of the PAR are within 5 hours travel to
any of the n facilities (Eq 4). To avoid spatial clustering within samples, we utilised an inhibitory
sampling approach when generating Ŝn, ensuring a minimum distance of 4km between sampled
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The minimal number of facilities, Nmin, was identified as the lowest value of n for which
both Qn and Zn > 0.
Deriving the optimal placement of facilities when the facility number is
known
To demonstrate how our approach can be used to determine the optimal placement of a fixed
number of facilities when the target number to retain is known (i.e. informed by the above
simulation, or when predefined by disease surveillance budgets), we implemented a further
simulation analysis. For this simulation, when given a fixed number of facilities, n, we wish to
identify the optimal subset of n facilities, from the 170 available which results in the highest
percentage of the PAR within 1-hour and 5-hour travel. N’dungu et al. [47], detail in their
work reporting on the Trypa-NO! project within north-western Uganda, that there is funding
available to retain a maximum of 51 g-HAT diagnostic facilities from the 170 facilities cur-
rently operational. Here, using 51 facilities as an example, we demonstrate how the optimal
placement of these facilities can be determined from an existing distribution using a cost-dis-
tance simulation. It should be noted that the number of available combinations (C(170, 51)) is
computationally prohibitive, therefore we employed a simulation approach utilising 10,000
random combinations of 51 facilities. For each sample, the total population within 1-hour and
5-hour of a facility was determined utilising a cost-distance analysis (Aj51 and B
j
51 respectively,
j = 1,. . .,10000). For these simulations, we did not employ an inhibitory sampling approach,
with no minimal distance enforced between selected facilities within each sample. The optimal
selection of the 51 facilities was the combination that resulted in the largest number of the
PAR being within the pre-defined criteria, as determined by a cumulative rank assessing per-
centage coverage within both 1-hour and 5-hour thresholds.
As a baseline for which to assess the impact of a scale back on accessibility of the PAR, we
generated a cost-distance surface including all 170 facilities, representative of the situation in
2017. We then compared the predicted travel time for each 30 × 30m cell under the optimal
scale back scenario, with the predicted travel time under the scenario representative of 2017, to
determine which geographic locations would be most affected.
Results
High-resolution resistance surface
The high-resolution resistance surface generated showed good agreement when compared
with freely obtained estimates of travel time from Google Maps, for 1,000 randomly generated
validation routes across north-western Uganda (R2 = 0.902, p<2e−16) (Fig 3A). The spatial dis-
tribution of the origin and destination locations used within the validation process is shown as
Fig 3B. Whilst there is strong correlation, modelled travel times are predicted to be slightly
slower when compared to Google (root-mean-square error = 14.98), this is likely due to our
estimates relating to motorbike based travel, vs Google times being representative of car travel.
Nonetheless, this validation process provided confidence in the resistance surface, and
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subsequently in our estimates of travel time to diagnostic facilities. To facilitate reproducibility
and additional research applications within the region, the resulting resistance surface is pro-
vided as S2 Data.
Deriving the minimal number of facilities
Results from the simulation experiment defined in Eqs 1–4 indicate that within north-western
Uganda, a minimum of three facilities are required to ensure that 50% of the PAR live within
1-hours travel of a HAT diagnostic facility, and a minimum of one facility is required to ensure
and 95% of the PAR live within 5-hours travel (Fig 4), when considering a subset (1000 simula-
tions) of all possible combinations of n facilities. These results, however, may be biased toward
highly populated areas (i.e. urban centres) and it is unlikely that an initial scale back of this
magnitude would be adopted by a national program due to a range of political and contextual
factors. We present a plot showing the median percentage of the population living outside of
1-hours travel time as Fig 4B. This plot demonstrates that to maintain similar levels of coverage
to that achieved by all 170 facilities in operation, scaling back to 51 facilities would ensure that
95.25% of the PAR would be within 1-hours travel of a facility, opposed to ~50% of the PAR
with the much reduced scale back to three facilities. We focus on this 1-hour threshold, as the
5-hour threshold is easily attained across our study area. Although we demonstrate that the
�50% within 1-hour and�95% within 5-hour coverage targets can be achieved with very few
facilities, our results question the effects of such a dramatic scale back on access inequality.
Coverage targets can be easily met by a low number of facilities if such facilities are located
within urban centres; this approach, however, may further isolate remote rural populations if
care isn’t taken when planning a scale back.
Deriving the optimal placement of facilities when the facility number is
known
As a baseline for which to assess the impact of a scale back on the accessibility of the PAR, we
first generated estimates of accessibility to all 170 facilities which were operational in 2017 (Fig
5A and 5B). The results from the cost-distance analysis utilising all 170 facilities indicate that
96.15% and 99.77% of the population at risk of HAT live within 1-hour and 5-hours travel
time of a HAT diagnostic facility in 2017 respectively.
Fig 3. A: Result of a linear regression comparing observed travel times from Google Maps, and modelled travel time
(our surface) (R2 = 0.902, p<2e−16). B: Spatial distribution of origin/destination locations (black dots) used to validate
the resistance surface. Blue lines represent pairing of origin/destination locations used to inform the regression
presented in A.
https://doi.org/10.1371/journal.pntd.0008599.g003
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Fig 4. A: Results from the simulation to derive the minimal number of facilities required to ensure 50% of the
population live within 1-hour travel time of a facility with HAT diagnostics (green) and 95% of the population live
within 5-hours travel time of a facility with HAT diagnostics (blue). Results are shown as the percentage of simulations
(from a total of 1000) which meet the�50% and�95% coverage targets. B: Median population (expressed as a
percentage) living outside of 1-hours travel, across all 1000 simulations per n facilities. Grey represents the maximum
and minimum % coverage value obtained across all 1000 simulations per n facilities.
https://doi.org/10.1371/journal.pntd.0008599.g004
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Fig 5. Predicted travel time, in minutes, to a g-HAT diagnostic facility. A) Predicted travel time (in minutes) to reach a diagnostic facility within north-
western Uganda, assuming the comprehensive distribution of 170 facilities. B) The predicted travel time surface detailed in A, presented as a categorical surface.
C) Predicted travel time (in minutes) to reach a diagnostic facility within north-western Uganda, using the scaled-back number (n = 51; (47)) of facilities, with
placement derived from the simulation study. D) The predicted travel time surface detailed in C, presented as a categorical surface. E) The difference in travel
time, for each gridded cell, between surfaces A and C. Red cells indicate geographic areas where the increase predicted travel time, in the event of scale back, is
greatest. F) The location of the optimal placement for the 51 facilities. Yellow pixels (30m x 30m) show the realised distribution of the population at risk, where
each pixel represents one or more individuals living inside of the mask for the buffered case data (mask shown as dark grey). The black line running through the
centre of our study area represents the Albert Nile river. Maps produced in QGIS [43].
https://doi.org/10.1371/journal.pntd.0008599.g005
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To demonstrate the ability of this approach to identify the optimal placement of facilities
when the facility number is known, either as derived from the above simulation, or pre-
defined, we generated 10,000 estimates of travel time to facilities under varying selection com-
binations of 51 facilities, the number operating from late 2018 onwards [47]. For each simula-
tion, we evaluated the percentage of individuals living within each coverage category (i.e.
within 1-hour and 5-hours travel of a facility). The optimal placement of the 51 facilities, from
the available distribution of 170 operational facilities resulted in no significant difference in
the proportion of the PAR living within 1-hours travel of a facility, when compared to the esti-
mate utilising all 170 facilities (P = 0.91; all 170 facilities = 96.15%, 51 facilities = 95.25% cover-
age). As expected, the coverage of the PAR within 1-hour travel, when quantified using the
optimal placement of these 51 facilities far exceeds the in-country coverage target of 50%.
Although our 10,000 simulations were only a subset of the total possible combination of 51
facilities from a set of 170, (C(170, 51)), we show that multiple combinations results in cover-
age estimates with negligible differences, particularly in reference to the 5-hour threshold (Fig
6). Of our 10,000 simulations, 9920 (99.2%) are estimated to have a 5-hour threshold coverage
above 99.7% (meeting the coverage value if all 170 facilities are considered). Of these, 9028
(90.28%) have a 1-hour threshold coverage above 90%, whereas the 1-hour coverage is 96.15%
if all 170 facilities are considered. We know that the maximum possible coverage cannot
exceed that obtained using all 170 facilities (96.15%). As a result, while there may exist an
excluded combination that exceeds the coverage obtained by the best identified set in our sim-
ulation (95.25%), any improvement would be marginal and negligible (at most 0.9%).
A comparison showing the accessibility to diagnostic facilities is given in Fig 5, detailing
accessibility to all 170 facilities in operation during 2017 (Fig 5A and 5B) and the scaled back
number of 51 facilities operating from late 2018 [47], with the optimal placement determined
through our approach (Fig 5C and 5D). To aid interpretation, we visualise the cost-distance
Fig 6. Result of the simulation to determine the optimal combination of 51 facilities, from a total of 10,000
combinations. Each dot represents the result of a single simulation containing a randomly sampled combination of 51
facilities, derived from a total set of 170 unique facilities within north-western Uganda. Due to the majority of
simulations far exceeding the 5-hour target, the Y axis is shown as the range 99.700–99.800.
https://doi.org/10.1371/journal.pntd.0008599.g006
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surfaces on a continuous scale (Fig 5A and 5C), and on a categorical scale, with travel time
binned by 30 minute increments (Fig 5B and 5D). The difference in travel time from each 30m
x 30m gridded cell, between all 170 facilities and 51 facilities is given in Fig 5E. A map detailing
the optimal placement of the scaled back facilities is provided as Fig 5F, and a table listing the
name, district and parish of facilities to preserve is provided (Table B in S1 File).
Areas of greatest travel time to a facility include those locations which have a low popula-
tion density, such as Maaji Parish in South-West Adjumani; Waka Parish in Obongi County,
Moyo District and Kei Fr Parish in Aringa county, Yumbe District South-West, among others.
Additionally, large areas of Southern Arua have populations living�1-hour of a diagnostic
facility, however, these populations are not generally considered to be living within areas of g-
HAT risk so do not affect the population coverage estimates generated here. Maps showing Fig
5 masked by the population at risk are provided as Fig B in S1 File.
Discussion
Twenty years of a global programme for active screening and treatment of g-HAT has driven the
global incidence to a historic low [17]. Building on this achievement, recent advances in methods
for detecting and treating g-HAT [18,42], combined with more cost-effective methods of tsetse
control [24], are providing the platform for achieving the WHO goals of eliminating g-HAT as a
public health problem by 2020 and interrupting transmission completely by 2030. There will be
a need for technical guidance on how to monitor the distribution and incidence of g-HAT in
this elimination setting. Establishing cost-effective surveillance systems that can be maintained
over the next decade will be crucial for the achievement of these ambitious goals.
Using a resistance surface informed by motorbike based travel, and a simulation-based
analysis, we determined that the number of operational g-HAT diagnostic facilities within
north-western Uganda could be reduced from 170 to three (Fig 4), whilst ensuring that per-
centage coverage targets of�50% of the PAR living within 1-hours travel and�95% 5-hours
travel are met. Ensuring that�95% of the PAR lives within 5-hours travel of a facility can be
achieved by retaining only one well-placed facility. This implies that such targets are easily
attainable within the geographic extent of our study area. Scaling back to this degree however
poses concerns regarding equity of access [48]. For a disease like g-HAT, which predominantly
affects rural populations, severe scaling back to achieve moderate targets could leave remote
communities without coverage. Ultimately, the degree of scale back should result from discus-
sions with programme implementers and stakeholders, utilising empirical evidence from anal-
yses such as those performed here in addition to the consideration of other operational and
contextual factors. Given that it is known that a small number of facilities is enough to achieve
the coverage targets, this methodology allows more ambitious targets of coverage to be consid-
ered. Specifically, we demonstrate that the number of facilities can be reduced by 70% with
minimal loss of coverage. Through the scale back of the number of facilities, we can improve
cost-effectiveness whilst preserving coverage of the entire PAR, including remote populations.
These simulations can be easily repeated as the spatial distribution of the PAR changes over
time, through substitution of new surfaces detailing contracting or expanding PAR in response
to case detection. This will allow a dynamic and rapid response to changing circumstances.
The PAR used in this analysis captures the historic distribution of g-HAT within north-west-
ern Uganda and is therefore greater than PAR surfaces generated using only contemporary
data (e.g. Simarro et al. [45]). Our results could however be applied to more recent infection
periods.
In this study, national borders, such as those with the neighbouring countries of South
Sudan and the Democratic Republic of the Congo, are presumed to prevent individuals who
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are citizens of either of those two countries from seeking diagnosis within Uganda. Conversely,
sub-national borders, (e.g., districts) are presumed not to prevent movement of individuals
seeking treatment. As the population density surface used to construct the PAR surface per-
tains to individuals living within Uganda only, we currently do not capture international
movement from neighbouring countries. Our friction surface would need to be expanded to
include areas within DRC or South Sudan if we wish to include these populations in our simu-
lations. The methodology described here, although applied to the surveillance of HAT, can
also be adapted for a range of elimination scenarios and can also be utilised for the monitoring
of emerging diseases as part of national early-warning systems.
Accessibility to a healthcare facility does not correlate precisely with Euclidean distance
[49]. The use of a validated resistance surface accounts for varying land cover and road net-
work accessibility, factors ultimately affecting travel time, especially for remote and rural com-
munities. Due to data limitations, associated mostly with the clarity of remotely sensed
imagery for characterising off-road travel, our resistance surface is representative of travel dur-
ing the dry season only. Travel to diagnostic facilities will be more difficult during the wet sea-
son, particularly along untarmacked roads. By producing our resistance surface at a high
spatial resolution, we also provide a more accurate quantification of travel time to a facility
than existing surfaces at coarser granularity [50], giving higher precision when quantifying
populations within each travel time category. Whilst the time taken to access a facility likely
influences an individual’s decision to seek treatment, additional factors are also at play. Future
efforts should investigate the use of spatial interaction models to quantify the influence of
other metrics on the probability of treatment seeking at a specific location, i.e. gravity models
weighted by staff capacity and their levels of training, status of the laboratory and available
materials for instance [51,52]. The construction and validation of such models requires empir-
ical measurements of treatment-seeking behaviour [53]. Our analysis investigated the optimal
retention of facilities in a specific spatial setting. The quality of services available at some facili-
ties will be different to others, however, our approach is sufficiently flexible to allow users to
retain required sites (for example, specialist referral centres), and there is scope for national
health systems to reallocate resources based on the spatial selection identified.
Although the travel time targets utilised within this analysis were pre-defined [16], further
analysis is required to determine the effects of these targets on treatment seeking behaviours.
For instance, the cost of continuous travel to a facility which is 1-hour or more from an indi-
vidual’s residence may present significant barriers to treatment [32], and our analysis shows,
that within north-western Uganda,�95% of the population are within 5-hours travel to just
one well-placed facility, questioning the value of this target for this area. Reducing the number
of accessible facilities may also influence factors such as compliance with post-treatment follow
up, with a previous study identifying costs for transportation to a facility as a reason for non-
completion of treatment [54]. Alongside any adopted scale-back approaches, there is a need
for sensitisation and information campaigns to inform the PAR of the reduced availability of
diagnostics as this information may influence treatment seeking behaviours [55]; this cam-
paign can be used alongside a referral system to address such issues.
Scale back of disease surveillance should be integrated within a national development plan
and combined with the scale back of intervention programmes. In the context of Uganda,
work is ongoing to investigate the effect of reducing the geographical extent of tsetse control
operations to areas where g-HAT persists. As disease prevalence changes within a geographic
area, approaches are required to ensure that appropriate surveillance and treatment systems
are in place. The method described here aims to ensure maximal coverage of surveillance
under the most cost-effective scenarios. For national programmes to adopt an optimised
approach and integrate this approach within health care delivery systems, it is important to
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demonstrate that the PAR remains adequately covered, health facilities are accessible, and that
a functional referral system is maintained. Providing strategic health facilities with a full range
of tests for disease confirmation is critical for elimination.
For other NTDs, plans to scale back surveillance require careful consideration of the coun-
try and disease in question, alongside additional context-specific factors [1]. As such, the alter-
ing of disease surveillance systems should be an iterative process requiring regular
reassessment of objectives and methods [9]. The approach described here provides a robust,
reproducible framework to ensure maximal coverage of the PAR through the minimal number
of sites within a passive disease surveillance system.
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